Spruce Biosciences, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Spruce Biosciences, Inc. (SPRB) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $3.75 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-09
- Spruce Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $3.75M, a 2854.33% increase from fiscal 2024.
- Spruce Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $127.00K, a 94.21% decline from fiscal 2023.
- Spruce Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $2.19M, a 3384.13% increase from fiscal 2022.
- Spruce Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $63.00K, a 68.18% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $3.75M 10-K · filed 2026-03-09 |
| 2024-12-31 | $127.00K 10-K · filed 2026-03-09 |
| 2023-12-31 | $2.19M 10-K · filed 2025-04-15 |
| 2022-12-31 | $63.00K 10-K · filed 2024-03-18 |
| 2021-12-31 | $198.00K 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |